Literature DB >> 6946758

Atrial fibrillation and arterial embolism in hyperthyroidism.

D M Hurley, A N Hunter, M J Hewett, J R Stockigt.   

Abstract

Atrial fibrillation or flutter was present in 70 of 381 patients with uncontrolled hyperthyroidism; return to stable sinus rhythm occurred in 39 with antithyroid and antiarrhythmic treatment. One third of the patients who reverted did so in the first week of treatment while still hyperthyroid. As expected, reversion was more likely in younger patients, and in those with arrhythmia of recent onset, without evidence of other heart disease. Eight patients with arrhythmia had proven (five) or probable (three) major arterial embolic episodes. Four of these eight patients died. Embolism tended to occur at an early stage, during uncontrolled hyperthyroidism, in patients with both atrial fibrillation and cardiac failure. These findings suggest that prophylactic anticoagulation may be appropriate in this high risk group, although more extensive studies are necessary before effective prevention of embolism can be claimed.

Entities:  

Mesh:

Year:  1981        PMID: 6946758     DOI: 10.1111/j.1445-5994.1981.tb03519.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  9 in total

Review 1.  Risk factors for stroke and primary prevention of stroke in atrial fibrillation.

Authors:  A Laupacis; D Singer; A Jacobsen; M Dunn; J Dalen; G Albers
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 2.  Embolic risk in atrial fibrillation that arises from hyperthyroidism: review of the medical literature.

Authors:  Elie Traube; Neil L Coplan
Journal:  Tex Heart Inst J       Date:  2011

3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

4.  Electrical cardioversion for persistent atrial fibrillation after treatment of thyrotoxicosis.

Authors:  P Emery; J S Staffurth
Journal:  Postgrad Med J       Date:  1982-12       Impact factor: 2.401

Review 5.  Thyroid, hemostasis and thrombosis.

Authors:  F Marongiu; C Cauli; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

6.  The role of hyperthyroidism as the predisposing factor for superior sagittal sinus thrombosis.

Authors:  Jong-Uk Hwang; Ki-Young Kwon; Jin-Woo Hur; Jong-Won Lee; Hyun-Koo Lee
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2012-09-28

Review 7.  Atrial Fibrillation and Its Association with Endocrine Disorders.

Authors:  Manjari Devidi; Avanija Buddam; Sunil Dacha; D Sudhaker Rao
Journal:  J Atr Fibrillation       Date:  2014-02-28

8.  Cardiovascular complications secondary to Graves' disease: a prospective study from Ukraine.

Authors:  Iryna Tsymbaliuk; Dmytro Unukovych; Nataliia Shvets; Andrii Dinets
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

9.  Left ventricular mural thrombus and dual coronary embolization associated with hyperthyroid cardiomyopathy and atrial fibrillation: a case report.

Authors:  Guohui Liu; Ping Yang; Yuquan He
Journal:  BMC Cardiovasc Disord       Date:  2017-05-19       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.